ConductScience.org, home

Trial · NCT01865747

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall Study (ITT)STARTEDCabozantinib (XL184)330
Overall Study (ITT)STARTEDEverolimus (Afinitor)328
Overall Study (ITT)COMPLETEDCabozantinib (XL184)132
Overall Study (ITT)COMPLETEDEverolimus (Afinitor)73
Overall Study (ITT)NOT COMPLETEDCabozantinib (XL184)198
Overall Study (ITT)NOT COMPLETEDEverolimus (Afinitor)255
Primary Intent to Treat (PITT)STARTEDCabozantinib (XL184)187
Primary Intent to Treat (PITT)STARTEDEverolimus (Afinitor)188
Primary Intent to Treat (PITT)COMPLETEDCabozantinib (XL184)56
Primary Intent to Treat (PITT)COMPLETEDEverolimus (Afinitor)36
Primary Intent to Treat (PITT)NOT COMPLETEDCabozantinib (XL184)131
Primary Intent to Treat (PITT)NOT COMPLETEDEverolimus (Afinitor)152

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01865747/flow